Total Payments
$1,359
2024 Payments
$623.57
Companies
16
Transactions
42
Medicare Patients
1,492
Medicare Billing
$138,679
Payment Breakdown by Category
Food & Beverage$1,359 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,359 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $340.63 | 3 | $0 (2023) |
| Amgen Inc. | $252.92 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $221.52 | 7 | $0 (2024) |
| Novo Nordisk Inc | $160.09 | 3 | $0 (2024) |
| Lilly USA, LLC | $102.32 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $59.81 | 3 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $46.40 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $33.31 | 2 | $0 (2024) |
| ABBVIE INC. | $31.32 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $20.48 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.57 | 20 | Amgen Inc. ($215.26) |
| 2023 | $499.30 | 14 | Horizon Therapeutics plc ($240.63) |
| 2022 | $172.74 | 6 | Horizon Therapeutics plc ($100.00) |
| 2021 | $63.09 | 2 | Mallinckrodt Hospital Products Inc. ($46.40) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Bone Health | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Biological | ||||||
| 09/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $91.40 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Inflammation | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Respiratory | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardio-renal | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.14 | General |
| 02/22/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $136.96 | General |
| 02/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Bone Health | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Inflammation | ||||||
| 01/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neuropsychiatry | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $57.47 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Biological | ||||||
| 10/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiology | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 338 | 444 | $96,688 | $29,947 |
| 2022 | 6 | 402 | 535 | $112,335 | $36,761 |
| 2021 | 6 | 384 | 580 | $115,091 | $40,914 |
| 2020 | 5 | 368 | 524 | $94,332 | $31,057 |
Total Patients
1,492
Total Services
2,083
Medicare Billing
$138,679
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 107 | 107 | $32,100 | $11,806 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 109 | 185 | $36,942 | $10,793 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 62 | 82 | $11,070 | $3,126 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 24 | $7,008 | $2,138 | 30.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 27 | $5,616 | $1,361 | 24.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 16 | 19 | $3,952 | $722.61 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 134 | 252 | $49,380 | $15,032 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 127 | 127 | $36,638 | $14,279 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 77 | 89 | $12,461 | $3,431 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 24 | $6,852 | $2,193 | 32.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 15 | $3,000 | $855.09 | 28.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 13 | 14 | $2,800 | $633.30 | 22.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 2022 | 14 | 14 | $1,204 | $336.59 | 28.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 142 | 319 | $54,106 | $19,297 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 119 | 119 | $37,961 | $13,634 | 35.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 65 | 75 | $7,901 | $2,972 | 37.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 23 | 32 | $8,384 | $2,719 | 32.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 12 | 12 | $5,796 | $1,741 | 30.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 2021 | 23 | 23 | $943.00 | $549.93 | 58.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 134 | 134 | $41,004 | $13,632 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 119 | 253 | $38,991 | $11,548 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 84 | 104 | $6,864 | $3,126 | 45.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 21 | $5,271 | $1,399 | 26.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Facility | 2020 | 12 | 12 | $2,202 | $1,353 | 61.4% |
About Carrie Powell, NP
Carrie Powell, NP is a Nurse Practitioner healthcare provider based in Great Falls, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093812265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carrie Powell, NP has received a total of $1,359 in payments from pharmaceutical and medical device companies, with $623.57 received in 2024. These payments were reported across 42 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,359).
As a Medicare-enrolled provider, Powell has provided services to 1,492 Medicare beneficiaries, totaling 2,083 services with total Medicare billing of $138,679. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Great Falls, MT
- Active Since 09/20/2006
- Last Updated 04/08/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1093812265
Products in Payments
- KRYSTEXXA (Biological) $340.63
- AIRSUPRA (Drug) $164.60
- Wegovy (Drug) $125.00
- MOUNJARO (Drug) $102.32
- Otezla (Drug) $57.04
- ACTHAR (Biological) $46.40
- EVENITY (Biological) $37.75
- Veozah (Drug) $33.31
- AREXVY (Drug) $29.98
- TRELEGY ELLIPTA (Drug) $29.83
- Repatha (Biological) $21.17
- INGREZZA (Drug) $20.48
- Crysvita (Drug) $19.49
- Rybelsus (Drug) $18.40
- QULIPTA (Drug) $18.06
- FARXIGA (Drug) $16.77
- Ozempic (Drug) $16.69
- Kerendia (Drug) $15.43
- REXULTI (Drug) $14.49
- NURTEC ODT (Drug) $14.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Great Falls
Amber Molnar, Agacnp, AGACNP
Nurse Practitioner — Payments: $4,343
Nurse Practitioner $4,343
Bowen Trystianson, Dnp, DNP
Nurse Practitioner — Payments: $3,611
Nurse Practitioner $3,611
Ms. Elizabeth Oconnor, Fnp Aprn Msn Ccrn, FNP APRN MSN CCRN
Nurse Practitioner — Payments: $2,739
Nurse Practitioner $2,739
Whitney Mckinley, Fnp-C, FNP-C
Nurse Practitioner — Payments: $2,287
Nurse Practitioner $2,287
Vilma Herrera, Agnp, AGNP
Nurse Practitioner — Payments: $1,749
Nurse Practitioner $1,749
Jessica Boso, Fnp, FNP
Nurse Practitioner — Payments: $1,157
Nurse Practitioner $1,157